United States Biotechnology & Medical Research

Neumora Therapeutics Inc (NMRA)

Track

Track

Neumora Therapeutics experienced significant insider trading activity recently, with executive Daljit Singh executing multiple sell transactions totaling over $700,000. These divestments occurred shortly after the company's August 14th earnings report. The stock has faced downward pressure, declining 52.3% over the past quarter, while trading near the lower end of its annual range.
Ticker: NMRA Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Neumora Therapeutics Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
3.5
Aurora Daljit Singh See Remarks Officer
Transaction date
Sale
Price
466.31
Quantity 31,669 -5.0%
Value US$3,288,703
3.5
Aurora Daljit Singh See Remarks Officer
Transaction date
Sale
Price
394.76
Quantity 36,754 -33.5%
Value US$645,805
3.5
Aurora Daljit Singh Officer Officer
Transaction date
Proposed sale
Price
245.35
Quantity 97,653
Value US$4,551,612
3.5
Aurora Daljit Singh See Remarks Officer
Transaction date
Sale
Price
1.51
Quantity 66,711 -100.0%
Value US$101,000
3.5
Aurora Daljit Singh See Remarks Officer
Transaction date
Sale
Price
1.51
Quantity 67,741 -58.2%
Value US$102,587
3.5
Aurora Daljit Singh Officer Officer
Transaction date
Proposed sale
Price
1.51
Quantity 134,452
Value US$203,584
3.5
Aurora Daljit Singh See Remarks Officer
Transaction date
Sale
Price
1.65
Quantity 30,918 -100.0%
Value US$50,888
3.5
Aurora Daljit Singh See Remarks Officer
Transaction date
Sale
Price
1.65
Quantity 31,000 -38.9%
Value US$51,029
3.5
Aurora Daljit Singh Officer Officer
Transaction date
Proposed sale
Price
1.65
Quantity 61,918
Value US$101,917
3.5
Aurora Daljit Singh See Remarks Officer
Transaction date
Sale
Price
1.59
Quantity 34,987 -100.0%
Value US$55,486
3.5
Aurora Daljit Singh See Remarks Officer
Transaction date
Sale
Price
1.58
Quantity 34,162 -41.2%
Value US$54,137
3.5
Aurora Daljit Singh Officer Officer
Transaction date
Proposed sale
Price
1.59
Quantity 69,149
Value US$109,622
3.5
Aurora Daljit Singh See Remarks Officer
Transaction date
Sale
Price
1.50
Quantity 55,016 -100.0%
Value US$82,783
3.5
Aurora Daljit Singh See Remarks Officer
Transaction date
Sale
Price
1.49
Quantity 34,020 -41.1%
Value US$50,530
3.5
Aurora Daljit Singh See Remarks Officer
Transaction date
Sale
Price
1.51
Quantity 57,670 -41.1%
Value US$86,822
3.5
Aurora Daljit Singh Officer Officer
Transaction date
Proposed sale
Price
1.50
Quantity 146,706
Value US$220,135
3.5
Aurora Daljit Singh See Remarks Officer
Transaction date
Sale
Price
3.56
Quantity 6,165 -6.9%
Value US$21,917
3.3
Pinto Joshua President Officer
Transaction date
Sale
Price
3.54
Quantity 5,967 -9.4%
Value US$21,093
2.0
BERNS PAUL L See Remarks Executive Director
Transaction date
Sale
Price
3.51
Quantity 9,819 -0.1%
Value US$34,459
Milligan Michael Lee See Remarks Officer
Transaction date
Planned sale
Price
3.57
Quantity 1,436 -6.4%
Value US$5,119
Milligan Michael Lee Officer Officer
Transaction date
Proposed sale
Price
3.57
Quantity 1,436
Value US$5,119
3.3
Pinto Joshua Officer Officer
Transaction date
Proposed sale
Price
3.54
Quantity 5,967
Value US$21,093
3.5
Aurora Daljit Singh Officer Officer
Transaction date
Proposed sale
Price
3.56
Quantity 6,165
Value US$21,917
2.0
BERNS PAUL L Officer Officer
Transaction date
Proposed sale
Price
3.51
Quantity 9,819
Value US$34,459
3.5
Aurora Daljit Singh See Remarks Officer
Transaction date
Planned sale
Price
2.68
Quantity 114,703 -100.0%
Value US$307,026
3.5
Aurora Family Trust Director; Officer Executive Director
Transaction date
Proposed sale
Price
2.68
Quantity 114,703
Value US$307,027
3.2
Burow Kristina Non-Executive Director Large shareholder
Transaction date
Purchase
Price
2.61
Quantity 1,915,700 +46.4%
Value US$4,999,977
3.2
Henry Gosebruch Officer; Director Executive Director
Transaction date
Proposed sale
Price
1.43
Quantity 15,000
Value US$21,450
2.0
BERNS PAUL L See Remarks Executive Director
Transaction date
Planned sale
Price
1.69
Quantity 13,871 -0.2%
Value US$23,468
3.5
Aurora Daljit Singh Chief Strategy Officer Officer
Transaction date
Planned sale
Price
1.68
Quantity 8,565 -8.8%
Value US$14,347
3.3
Pinto Joshua President Officer
Transaction date
Planned sale
Price
1.67
Quantity 8,048 -9.5%
Value US$13,477
Milligan Michael Lee See Remarks Officer
Transaction date
Planned sale
Price
1.69
Quantity 1,978 -8.1%
Value US$3,351
Lenz Robert A. Head of R&D Officer
Transaction date
Planned sale
Price
1.67
Quantity 5,614 -1.8%
Value US$9,383
Suh Carol Y. Officer Officer
Transaction date
Proposed sale
Price
1.68
Quantity 9,540
Value US$16,020
Milligan Michael Lee Officer Officer
Transaction date
Proposed sale
Price
1.69
Quantity 1,978
Value US$3,351
3.3
Pinto Joshua Officer Officer
Transaction date
Proposed sale
Price
1.67
Quantity 8,048
Value US$13,478
Lenz Robert A. Officer Officer
Transaction date
Proposed sale
Price
1.67
Quantity 5,614
Value US$9,383
3.2
Gosebruch Henry O Officer; Director Executive Director
Transaction date
Proposed sale
Price
1.67
Quantity 6,857
Value US$11,462
2.0
BERNS PAUL L Officer Officer
Transaction date
Proposed sale
Price
1.69
Quantity 13,871
Value US$23,468
3.5
Aurora Daljit Singh Officer Officer
Transaction date
Proposed sale
Price
1.68
Quantity 8,565
Value US$14,348
3.8
Fust Matthew K Director Non-Executive Director
Transaction date
Proposed sale
Price
17.03
Quantity 14,049
Value US$239,319
3.8
Fust Matthew K Non-Executive Director
Transaction date
Planned sale
Price
17.03
Quantity 14,049 -41.1%
Value US$239,319
3.8
Fust Matthew K Non-Executive Director
Transaction date
Planned sale
Price
17.01
Quantity 7,739 -27.8%
Value US$131,643
3.8
Fust Matthew K Director Non-Executive Director
Transaction date
Proposed sale
Price
17.01
Quantity 7,739
Value US$131,643
Lenz Robert A. Head of R&D Officer
Transaction date
Planned sale
Price
15.09
Quantity 8,260 -2.6%
Value US$124,603
Lenz Robert A. Officer Officer
Transaction date
Proposed sale
Price
15.09
Quantity 8,260
Value US$124,603
Lenz Robert A. Head of R&D Officer
Transaction date
Planned sale
Price
15.01
Quantity 5,563 -1.7%
Value US$83,507
Lenz Robert A. Officer Officer
Transaction date
Proposed sale
Price
15.01
Quantity 5,563
Value US$83,507
Lenz Robert A. Head of R&D Officer
Transaction date
Planned sale
Price
12.09
Quantity 10,676 -3.1%
Value US$129,091
Lenz Robert A. Officer Officer
Transaction date
Proposed sale
Price
12.09
Quantity 10,676
Value US$129,091
Lenz Robert A. Head of R&D Officer
Transaction date
Planned sale
Price
11.81
Quantity 30,788 -8.3%
Value US$363,736
Lenz Robert A. Officer Officer
Transaction date
Proposed sale
Price
11.81
Quantity 30,788
Value US$363,734
Lenz Robert A. Head of R&D Officer
Transaction date
Planned sale
Price
11.43
Quantity 32,948 -8.2%
Value US$376,665
Lenz Robert A. Officer Officer
Transaction date
Proposed sale
Price
11.43
Quantity 32,948
Value US$376,665
3.3
Pinto Joshua Chief Financial Officer Officer
Transaction date
Planned sale
Price
11.39
Quantity 15,693 -10.1%
Value US$178,806
3.3
Pinto Joshua Chief Financial Officer Officer
Transaction date
Planned sale
Price
11.78
Quantity 31,642 -17.0%
Value US$372,588
3.3
Pinto Joshua Chief Financial Officer Officer
Transaction date
Planned sale
Price
11.59
Quantity 24,169 -11.5%
Value US$280,005
3.3
Pinto Joshua Chief Financial Officer Officer
Transaction date
Planned sale
Price
11.63
Quantity 28,496 -11.9%
Value US$331,468
3.3
Pinto Joshua Officer Officer
Transaction date
Proposed sale
Price
11.90
Quantity 100,000
Value US$1,190,000
3.2
Burow Kristina Non-Executive Director Large shareholder
Transaction date
Purchase
Price
11.98
Quantity 3,357 +0.1%
Value US$40,217
3.2
Burow Kristina Non-Executive Director Large shareholder
Transaction date
Purchase
Price
11.75
Quantity 31,653 +0.8%
Value US$371,923
3.2
Burow Kristina Non-Executive Director Large shareholder
Transaction date
Purchase
Price
11.75
Quantity 5,431 +0.1%
Value US$63,814
3.2
Burow Kristina Non-Executive Director Large shareholder
Transaction date
Purchase
Price
11.37
Quantity 11,844 +0.3%
Value US$134,666
3.2
Burow Kristina Non-Executive Director Large shareholder
Transaction date
Purchase
Price
10.53
Quantity 31,079 +0.8%
Value US$327,262
3.2
Burow Kristina Non-Executive Director Large shareholder
Transaction date
Purchase
Price
11.79
Quantity 23,124 +0.6%
Value US$272,632
3.2
Burow Kristina Non-Executive Director Large shareholder
Transaction date
Purchase
Price
10.78
Quantity 69,127 +1.7%
Value US$745,189
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-08-21 2026-08-21 S Sale
3.5
Aurora Daljit Singh

See Remarks

Officer
31,669 -5.0%
466.31
US$3,288,703 		31,669 -5.0% 466.31 US$3,288,703
2026-08-21 2026-08-21 S Sale
3.5
Aurora Daljit Singh

See Remarks

Officer
36,754 -33.5%
394.76
US$645,805 		36,754 -33.5% 394.76 US$645,805
2026-08-21 2026-08-21 PrS Proposed sale
3.5
Aurora Daljit Singh

Officer

Officer
97,653
245.35
US$4,551,612 		97,653 245.35 US$4,551,612
2026-08-21 2026-08-20 S Sale
3.5
Aurora Daljit Singh

See Remarks

Officer
66,711 -100.0%
1.51
US$101,000 		66,711 -100.0% 1.51 US$101,000
2026-08-21 2026-08-20 S Sale
3.5
Aurora Daljit Singh

See Remarks

Officer
67,741 -58.2%
1.51
US$102,587 		67,741 -58.2% 1.51 US$102,587
2026-08-20 2026-08-20 PrS Proposed sale
3.5
Aurora Daljit Singh

Officer

Officer
134,452
1.51
US$203,584 		134,452 1.51 US$203,584
2026-08-19 2026-08-19 S Sale
3.5
Aurora Daljit Singh

See Remarks

Officer
30,918 -100.0%
1.65
US$50,888 		30,918 -100.0% 1.65 US$50,888
2026-08-19 2026-08-19 S Sale
3.5
Aurora Daljit Singh

See Remarks

Officer
31,000 -38.9%
1.65
US$51,029 		31,000 -38.9% 1.65 US$51,029
2026-08-19 2026-08-19 PrS Proposed sale
3.5
Aurora Daljit Singh

Officer

Officer
61,918
1.65
US$101,917 		61,918 1.65 US$101,917
2026-08-19 2026-08-18 S Sale
3.5
Aurora Daljit Singh

See Remarks

Officer
34,987 -100.0%
1.59
US$55,486 		34,987 -100.0% 1.59 US$55,486
2026-08-19 2026-08-18 S Sale
3.5
Aurora Daljit Singh

See Remarks

Officer
34,162 -41.2%
1.58
US$54,137 		34,162 -41.2% 1.58 US$54,137
2026-08-18 2026-08-18 PrS Proposed sale
3.5
Aurora Daljit Singh

Officer

Officer
69,149
1.59
US$109,622 		69,149 1.59 US$109,622
2026-08-19 2026-08-17 S Sale
3.5
Aurora Daljit Singh

See Remarks

Officer
55,016 -100.0%
1.50
US$82,783 		55,016 -100.0% 1.50 US$82,783
2026-08-19 2026-08-17 S Sale
3.5
Aurora Daljit Singh

See Remarks

Officer
34,020 -41.1%
1.49
US$50,530 		34,020 -41.1% 1.49 US$50,530
2026-08-19 2026-08-17 S Sale
3.5
Aurora Daljit Singh

See Remarks

Officer
57,670 -41.1%
1.51
US$86,822 		57,670 -41.1% 1.51 US$86,822
2026-08-17 2026-08-17 PrS Proposed sale
3.5
Aurora Daljit Singh

Officer

Officer
146,706
1.50
US$220,135 		146,706 1.50 US$220,135
2026-02-19 2026-02-17 S Sale
3.5
Aurora Daljit Singh

See Remarks

Officer
6,165 -6.9%
3.56
US$21,917 		6,165 -6.9% 3.56 US$21,917
2026-02-19 2026-02-17 S Sale
3.3
Pinto Joshua

President

Officer
5,967 -9.4%
3.54
US$21,093 		5,967 -9.4% 3.54 US$21,093
2026-02-19 2026-02-17 S Sale
2.0
BERNS PAUL L

See Remarks

Executive Director
9,819 -0.1%
3.51
US$34,459 		9,819 -0.1% 3.51 US$34,459
2026-02-19 2026-02-17 PlS Planned sale
Milligan Michael Lee

See Remarks

Officer
1,436 -6.4%
3.57
US$5,119 		1,436 -6.4% 3.57 US$5,119
2026-02-17 2026-02-17 PrS Proposed sale
Milligan Michael Lee

Officer

Officer
1,436
3.57
US$5,119 		1,436 3.57 US$5,119
2026-02-17 2026-02-17 PrS Proposed sale
3.3
Pinto Joshua

Officer

Officer
5,967
3.54
US$21,093 		5,967 3.54 US$21,093
2026-02-17 2026-02-17 PrS Proposed sale
3.5
Aurora Daljit Singh

Officer

Officer
6,165
3.56
US$21,917 		6,165 3.56 US$21,917
2026-02-17 2026-02-17 PrS Proposed sale
2.0
BERNS PAUL L

Officer

Officer
9,819
3.51
US$34,459 		9,819 3.51 US$34,459
2025-11-13 2025-11-11 PlS Planned sale
3.5
Aurora Daljit Singh

See Remarks

Officer
114,703 -100.0%
2.68
US$307,026 		114,703 -100.0% 2.68 US$307,026
2025-11-12 2025-11-11 PrS Proposed sale
3.5
Aurora Family Trust

Director; Officer

Executive Director
114,703
2.68
US$307,027 		114,703 2.68 US$307,027
2025-10-29 2025-10-27 B Purchase
3.7
ARCH Venture Partners XII, LLC
Large shareholder
1,915,700 +46.4%
2.61
US$4,999,977 		1,915,700 +46.4% 2.61 US$4,999,977
2025-10-29 2025-10-27 B Purchase
3.2
Burow Kristina
Non-Executive Director Large shareholder
1,915,700 +46.4%
2.61
US$4,999,977 		1,915,700 +46.4% 2.61 US$4,999,977
2025-10-29 2025-10-27 B Purchase
3.4
ARCH Venture Partners X, LLC
Large shareholder
1,915,700 +46.4%
2.61
US$4,999,977 		1,915,700 +46.4% 2.61 US$4,999,977
2025-03-12 2025-03-12 PrS Proposed sale
3.2
Henry Gosebruch

Officer; Director

Executive Director
15,000
1.43
US$21,450 		15,000 1.43 US$21,450
2025-02-20 2025-02-18 PlS Planned sale
2.0
BERNS PAUL L

See Remarks

Executive Director
13,871 -0.2%
1.69
US$23,468 		13,871 -0.2% 1.69 US$23,468
2025-02-20 2025-02-18 PlS Planned sale
3.5
Aurora Daljit Singh

Chief Strategy Officer

Officer
8,565 -8.8%
1.68
US$14,347 		8,565 -8.8% 1.68 US$14,347
2025-02-20 2025-02-18 PlS Planned sale
3.3
Pinto Joshua

President

Officer
8,048 -9.5%
1.67
US$13,477 		8,048 -9.5% 1.67 US$13,477
2025-02-20 2025-02-18 PlS Planned sale
Milligan Michael Lee

See Remarks

Officer
1,978 -8.1%
1.69
US$3,351 		1,978 -8.1% 1.69 US$3,351
2025-02-20 2025-02-18 PlS Planned sale
Lenz Robert A.

Head of R&D

Officer
5,614 -1.8%
1.67
US$9,383 		5,614 -1.8% 1.67 US$9,383
2025-02-18 2025-02-18 PrS Proposed sale
Suh Carol Y.

Officer

Officer
9,540
1.68
US$16,020 		9,540 1.68 US$16,020
2025-02-18 2025-02-18 PrS Proposed sale
Milligan Michael Lee

Officer

Officer
1,978
1.69
US$3,351 		1,978 1.69 US$3,351
2025-02-18 2025-02-18 PrS Proposed sale
3.3
Pinto Joshua

Officer

Officer
8,048
1.67
US$13,478 		8,048 1.67 US$13,478
2025-02-18 2025-02-18 PrS Proposed sale
Lenz Robert A.

Officer

Officer
5,614
1.67
US$9,383 		5,614 1.67 US$9,383
2025-02-18 2025-02-18 PrS Proposed sale
3.2
Gosebruch Henry O

Officer; Director

Executive Director
6,857
1.67
US$11,462 		6,857 1.67 US$11,462
2025-02-18 2025-02-18 PrS Proposed sale
2.0
BERNS PAUL L

Officer

Officer
13,871
1.69
US$23,468 		13,871 1.69 US$23,468
2025-02-18 2025-02-18 PrS Proposed sale
3.5
Aurora Daljit Singh

Officer

Officer
8,565
1.68
US$14,348 		8,565 1.68 US$14,348
2024-10-18 2024-10-18 PrS Proposed sale
3.8
Fust Matthew K

Director

Non-Executive Director
14,049
17.03
US$239,319 		14,049 17.03 US$239,319
2024-10-18 2024-10-18 PlS Planned sale
3.8
Fust Matthew K
Non-Executive Director
14,049 -41.1%
17.03
US$239,319 		14,049 -41.1% 17.03 US$239,319
2024-10-18 2024-10-17 PlS Planned sale
3.8
Fust Matthew K
Non-Executive Director
7,739 -27.8%
17.01
US$131,643 		7,739 -27.8% 17.01 US$131,643
2024-10-17 2024-10-17 PrS Proposed sale
3.8
Fust Matthew K

Director

Non-Executive Director
7,739
17.01
US$131,643 		7,739 17.01 US$131,643
2024-10-11 2024-10-10 PlS Planned sale
Lenz Robert A.

Head of R&D

Officer
8,260 -2.6%
15.09
US$124,603 		8,260 -2.6% 15.09 US$124,603
2024-10-10 2024-10-10 PrS Proposed sale
Lenz Robert A.

Officer

Officer
8,260
15.09
US$124,603 		8,260 15.09 US$124,603
2024-10-11 2024-10-09 PlS Planned sale
Lenz Robert A.

Head of R&D

Officer
5,563 -1.7%
15.01
US$83,507 		5,563 -1.7% 15.01 US$83,507
2024-10-09 2024-10-09 PrS Proposed sale
Lenz Robert A.

Officer

Officer
5,563
15.01
US$83,507 		5,563 15.01 US$83,507
2024-09-19 2024-09-18 PlS Planned sale
Lenz Robert A.

Head of R&D

Officer
10,676 -3.1%
12.09
US$129,091 		10,676 -3.1% 12.09 US$129,091
2024-09-18 2024-09-18 PrS Proposed sale
Lenz Robert A.

Officer

Officer
10,676
12.09
US$129,091 		10,676 12.09 US$129,091
2024-09-19 2024-09-17 PlS Planned sale
Lenz Robert A.

Head of R&D

Officer
30,788 -8.3%
11.81
US$363,736 		30,788 -8.3% 11.81 US$363,736
2024-09-17 2024-09-17 PrS Proposed sale
Lenz Robert A.

Officer

Officer
30,788
11.81
US$363,734 		30,788 11.81 US$363,734
2024-09-16 2024-09-12 PlS Planned sale
Lenz Robert A.

Head of R&D

Officer
32,948 -8.2%
11.43
US$376,665 		32,948 -8.2% 11.43 US$376,665
2024-09-12 2024-09-12 PrS Proposed sale
Lenz Robert A.

Officer

Officer
32,948
11.43
US$376,665 		32,948 11.43 US$376,665
2024-08-27 2024-08-27 PlS Planned sale
3.3
Pinto Joshua

Chief Financial Officer

Officer
15,693 -10.1%
11.39
US$178,806 		15,693 -10.1% 11.39 US$178,806
2024-08-26 2024-08-26 PlS Planned sale
3.3
Pinto Joshua

Chief Financial Officer

Officer
31,642 -17.0%
11.78
US$372,588 		31,642 -17.0% 11.78 US$372,588
2024-08-26 2024-08-23 PlS Planned sale
3.3
Pinto Joshua

Chief Financial Officer

Officer
24,169 -11.5%
11.59
US$280,005 		24,169 -11.5% 11.59 US$280,005
2024-08-26 2024-08-22 PlS Planned sale
3.3
Pinto Joshua

Chief Financial Officer

Officer
28,496 -11.9%
11.63
US$331,468 		28,496 -11.9% 11.63 US$331,468
2024-08-22 2024-08-22 PrS Proposed sale
3.3
Pinto Joshua

Officer

Officer
100,000
11.90
US$1,190,000 		100,000 11.90 US$1,190,000
2023-11-15 2023-11-14 B Purchase
3.7
ARCH Venture Partners XII, LLC
Large shareholder
3,357 +0.1%
11.98
US$40,217 		3,357 +0.1% 11.98 US$40,217
2023-11-15 2023-11-14 B Purchase
3.2
Burow Kristina
Non-Executive Director Large shareholder
3,357 +0.1%
11.98
US$40,217 		3,357 +0.1% 11.98 US$40,217
2023-11-15 2023-11-13 B Purchase
3.7
ARCH Venture Partners XII, LLC
Large shareholder
31,653 +0.8%
11.75
US$371,923 		31,653 +0.8% 11.75 US$371,923
2023-11-15 2023-11-13 B Purchase
3.2
Burow Kristina
Non-Executive Director Large shareholder
31,653 +0.8%
11.75
US$371,923 		31,653 +0.8% 11.75 US$371,923
2023-11-13 2023-11-10 B Purchase
3.7
ARCH Venture Partners XII, LLC
Large shareholder
5,431 +0.1%
11.75
US$63,814 		5,431 +0.1% 11.75 US$63,814
2023-11-13 2023-11-10 B Purchase
3.7
ARCH Venture Partners XII, LLC
Large shareholder
11,844 +0.3%
11.37
US$134,666 		11,844 +0.3% 11.37 US$134,666
2023-11-13 2023-11-10 B Purchase
3.2
Burow Kristina
Non-Executive Director Large shareholder
5,431 +0.1%
11.75
US$63,814 		5,431 +0.1% 11.75 US$63,814
2023-11-13 2023-11-10 B Purchase
3.2
Burow Kristina
Non-Executive Director Large shareholder
11,844 +0.3%
11.37
US$134,666 		11,844 +0.3% 11.37 US$134,666
2023-11-13 2023-11-09 B Purchase
3.7
ARCH Venture Partners XII, LLC
Large shareholder
31,079 +0.8%
10.53
US$327,262 		31,079 +0.8% 10.53 US$327,262
2023-11-13 2023-11-09 B Purchase
3.2
Burow Kristina
Non-Executive Director Large shareholder
31,079 +0.8%
10.53
US$327,262 		31,079 +0.8% 10.53 US$327,262
2023-11-13 2023-11-08 B Purchase
3.7
ARCH Venture Partners XII, LLC
Large shareholder
23,124 +0.6%
11.79
US$272,632 		23,124 +0.6% 11.79 US$272,632
2023-11-13 2023-11-08 B Purchase
3.7
ARCH Venture Partners XII, LLC
Large shareholder
69,127 +1.7%
10.78
US$745,189 		69,127 +1.7% 10.78 US$745,189
2023-11-13 2023-11-08 B Purchase
3.2
Burow Kristina
Non-Executive Director Large shareholder
23,124 +0.6%
11.79
US$272,632 		23,124 +0.6% 11.79 US$272,632
2023-11-13 2023-11-08 B Purchase
3.2
Burow Kristina
Non-Executive Director Large shareholder
69,127 +1.7%
10.78
US$745,189 		69,127 +1.7% 10.78 US$745,189
Explore more

More insider trading research around Neumora Therapeutics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America